These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 335500)
41. Hereditary nephropathy associated with hyperuricemia and gout. Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538 [TBL] [Abstract][Full Text] [Related]
42. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. Dalbeth N; Kumar S; Stamp L; Gow P J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857 [TBL] [Abstract][Full Text] [Related]
43. [Prevention of urinary calculi by means of a benzbromarone-citrate combination]. Bach D; Hesse A; Strenge A; Vahlensieck W Fortschr Med; 1980 Nov; 98(44):1752-5. PubMed ID: 7461567 [TBL] [Abstract][Full Text] [Related]
44. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus. Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511 [TBL] [Abstract][Full Text] [Related]
45. Urateoxidase in severe hyperuricemia during acute renal failure after heart transplantation. Ippoliti G; Negri M; Abelli P; Martinelli L; Minzioni G; Viganò M Haematologica; 1990; 75(5):487-8. PubMed ID: 2097272 [No Abstract] [Full Text] [Related]
46. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk. Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747 [TBL] [Abstract][Full Text] [Related]
48. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease. Panomvana D; Sripradit S; Angthararak S J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090 [TBL] [Abstract][Full Text] [Related]
49. [Effect of decrease in hyperuricemia levels on joint, kidney and other symptoms in patients with gout]. Kawenoki-Minc E Ter Arkh; 1987; 59(4):25-8. PubMed ID: 3589999 [No Abstract] [Full Text] [Related]
50. [Management of hyperuricemia in diabetes]. Hirai A; Saito Y Nihon Rinsho; 1997 Nov; 55 Suppl():781-5. PubMed ID: 9434564 [No Abstract] [Full Text] [Related]
51. Cyclosporine-induced hyperuricemia and gout. N Engl J Med; 1990 Feb; 322(5):334-6. PubMed ID: 2296276 [No Abstract] [Full Text] [Related]
52. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone]. Matzkies F Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850 [No Abstract] [Full Text] [Related]
53. Renal function and lipid metabolism in pregnant renal transplant recipients. Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508 [TBL] [Abstract][Full Text] [Related]
54. Hyperuricemia, gout, and renal function after liver transplantation. Neal DA; Tom BD; Gimson AE; Gibbs P; Alexander GJ Transplantation; 2001 Nov; 72(10):1689-91. PubMed ID: 11726834 [TBL] [Abstract][Full Text] [Related]
56. Effect of allopurinol drug use on GFR and proteinuria in patients with renal transplant recipients (ADOPTR study). Usalan Ö; Şahin AZ; Özdemir O; Cingöz M; Usalan C Transpl Immunol; 2022 Jun; 72():101560. PubMed ID: 35245661 [TBL] [Abstract][Full Text] [Related]